Director/PDMR Shareholding
2010年4月12日 - 3:00PM
RNSを含む英国規制内ニュース (英語)
TIDMCRYO
RNS Number : 0036K
Cryo-Save Group NV
12 April 2010
12 April 2010
Cryo-Save Group N.V.
Director/PDMR Shareholding
Cryo-Save Group N.V.(AIM/Euronext: CRYO, or 'the Group'), Europe's leading stem
cell bank, has been informed that Mr Marc Waeterschoot, Chief Executive Officer,
purchased 17,296 ordinary shares of Euro 0.10 ('Ordinary Shares') at a price
range between EUR5.66 and EUR5.70 between 7 April and 9 April 2010.
Following these purchases, Marc Waeterschoot is beneficially interested in
1,810,000 ordinary shares, representing approximately 19.60% of the Group's
issued share capital.
Enquiries:
+-------------------------------------+---------------------+
| Cryo-Save Group | +31 (0)575 548998 |
+-------------------------------------+---------------------+
| Marc Waeterschoot, Chief Executive | |
| Officer | |
+-------------------------------------+---------------------+
| Arnoud van Tulder, Chief Financial | |
| Officer | |
+-------------------------------------+---------------------+
| | |
+-------------------------------------+---------------------+
| Daniel Stewart & Company plc | +44 (0) 20 7776 |
| | 6550 |
+-------------------------------------+---------------------+
| Simon Leathers/Emma Earl | |
+-------------------------------------+---------------------+
| | |
+-------------------------------------+---------------------+
| College Hill (UK) | + 44 (0) 20 7457 |
| | 2020 |
+-------------------------------------+---------------------+
| Adrian Duffield/Rozi Morris | |
+-------------------------------------+---------------------+
| | |
+-------------------------------------+---------------------+
| SPJ Financiële Communicatie | +31 (0)20 647 8181 |
| Amstelveen (NL) | |
+-------------------------------------+---------------------+
| Kees Jongsma/Léon Melens | |
+-------------------------------------+---------------------+
About Cryo-Save
With more than 120,000 samples saved, Cryo-Save is the leading stem cell bank in
Europe and one of the fastest growing in the world. Driven by its international
business strategy, Cryo-Save is now represented in 38 countries on three
continents and has state-of-the-art processing facilities in Belgium, Germany,
Dubai, India and France (under construction).
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSLLFSRSEIAIII
Cryo-Save (LSE:CRYO)
過去 株価チャート
から 5 2024 まで 6 2024
Cryo-Save (LSE:CRYO)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Cryo-Save (ロンドン証券取引所): 0 recent articles
その他のCryo-Saveニュース記事